Christine Davis Appointed as New President of Ontada
Ontada, a McKesson business focusing on oncology real-world data and evidence, has appointed Christine Davis as [...]
The Illusions of the U.S. Pharmaceutical Industry: Misdirection in Drug Pricing, Innovation, and Regulation
The U.S. biopharmaceutical industry uses subtle illusion techniques similar to magicians to distract Americans from truths [...]
Seagen and Nurix Partner to Develop New Cancer Therapy, Deal Could Reach $3.4 Billion
Seattle-based biotech Seagen will partner with Nurix to develop degrader-antibody conjugates (DACs), a new type of cancer therapy. Seagen is [...]
Novo Nordisk’s Obesity Drugs Reshape Denmark’s Economy, Sparking Economic and Policy Debates
Novo Nordisk, a Danish firm initially known for producing diabetes drugs, has become highly influential on Denmark's economy due to [...]
Medicare to Negotiate Prices for 10 High-Cost Drugs Under New Democratic Reform Law
Medicare will negotiate prices for ten high-cost drugs, including major diabetes medications and blood thinners, as part of a drug [...]
Cellares Secures $255M in Series C Round of Funding
Cellares, a cell therapy manufacturer based in South San Francisco, announced a $255 million series C investment round to finish [...]
Leo Pharma Acquires Timber Pharmaceuticals for $36M to Bolster Dermatology Pipeline
Leo Pharma has agreed to acquire US-based Timber Pharmaceuticals, a clinical-stage biopharma company that develops treatments for rare skin conditions, [...]
Boehringer Ingelheim Files Lawsuit Against U.S. Government Over Medicare’s Drug Price Negotiation Power
Boehringer Ingelheim has filed a lawsuit against the U.S. government, arguing that Medicare's new power to negotiate drug prices is [...]
Bruker to Acquire PhenomeX for $108M
Bruker Corporation is actively acquiring PhenomeX in a cash deal valued at $108 million. PhenomeX, a product of Berkeley Lights' [...]
Preliminary Data Suggests Moderna’s Updated Covid-19 Vaccine Effective Against Expected Fall Variants
Moderna's preliminary data suggests that its updated COVID-19 vaccine can effectively combat expected variants this fall, including Eris and Fornax. [...]
Strategic Planning, Partnerships, and Compliance in Conflict Zones
Here's What You Need to Know: The PwC 25th Annual Global CEO Survey showed that geopolitical conflicts significantly threaten global [...]
FDA Approves Ipsen’s Ultra-Rare Bone Disease Drug Sohonos
The Food and Drug Administration (FDA) has approved Ipsen Pharmaceuticals' Sohonos, a drug designed to treat fibrodysplasia ossificans progressiva (FOP), [...]
FDA to Decide on Bluebird Bio’s Gene Therapy for Sickle Cell Disease
Bluebird Bio's gene therapy for Sickle Cell Disease (SCD), lovotibeglogene autotemcel (lovo-cel), is awaiting FDA approval, with the decision expected [...]
Federal Appeals Court Restricts Access to Abortion Pill Mifepristone
A federal appeals court has ruled to restrict access to the abortion pill mifepristone but has not removed it from [...]
Updates to Keep an Eye on
The FDA has fast-tracked approval of Pfizer's Elfrexfio drug for hard-to-treat multiple myeloma, offering new hope to patients. State and [...]
Rising Biotech Stocks: Key Players to Monitor
10 Things You Need to Know: Biotech stocks continue to prosper long-term despite periodic fluctuations. In 2020, prominent biotech companies [...]
Biopharma Companies Plan of Attack After COVID-19 Revenue Boom
The COVID era created new mass-market drugs and vaccines requiring substantial investments. However, investors and analysts urge companies to adapt [...]
Supreme Court Halts Purdue Pharma’s Bankruptcy Plan Worth Billions
The Supreme Court has ordered a temporary halt on the proposed bankruptcy plan for Purdue Pharma, [...]
Skepticism Surrounds NIH’s Long Covid Clinical Trials
The National Institutes of Health (NIH) initiated clinical trials for long Covid – persistent symptoms following [...]
Act4Biosimilars Advocacy Group Strives to Boost Global Adoption of Biosimilars by 2030
Act4Biosimilars, a global biosimilar advocacy initiative, aims to increase global adoption of biosimilars by at least [...]
BioMarin’s Voxzogo Sales Forecast Rises Despite Supply Constraints
Voxzogo's success is posing challenges for BioMarin. Here's what you need to know: BioMarin's drug, Voxzogo, is performing better than [...]
AI’s Impact and Challenges in the Medical Device and Pharmaceutical Industries
AI and technologies such as computer vision are profoundly influencing the medical device and pharmaceutical industries by bolstering safety, efficiency, [...]
Sarepta Therapeutics Begins Dosing Duchenne Patients with Newly Approved Gene Therapy
Sarepta Therapeutics has started dosing Duchenne muscular dystrophy patients with its recently approved gene therapy, Elevidys, and plans to serve [...]
Cost and Accessibility Concerns Over Lecanemab
The first drug aiming to slow the progression of Alzheimer's, lecanemab (brand name Leqembi), could cost the U.S. health care [...]
Medicare Drug Price Negotiations Predicted to Yield $1.8 Billion Savings by 2026
A new report asserts that the Inflation Reduction Act will enforce a minimum discount that surpasses the 2020 rebates for [...]